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Objective: To investigate the efﬁcacy of pomegranate (Punica granatum) peel extract as
an alternative treatment on the white laboratory mice against giardiasis.
Methods: Experimental animals were divided into ﬁve groups, including Group A:
control (infected untreated), Group B: infected and fed with pectin 7 days before
infection, Group C: infected and fed with pectin starting from 7th day of infection,
Group D: infected and fed with pomegranate peel extract 7 days before infection, and
Group E: infected and fed with pomegranate peel extract starting from 7th day of
infection.
Results: Results from this study revealed that the prevention rate in the experimental
groups reached approximately 50% by the 10th day of using pomegranate peel extract.
Moreover, stool cyst counts of groups showed a signiﬁcant reduction in the shedding of
cysts approximately 75.6% by day 20 post-infection. ELISA test showed a reduction in
Giardia antigen in the stools of the experimental groups which received pomegranate
peel extract. The cure rate of these groups was approximately 97.4% by 28th day of
infection.
Conclusions: Our present ﬁndings indicated that the pomegranate peel extract proved to
be valuable in prevention and treatment of Giardia lamblia infection. Further studies are
required to determine the effective dose of pomegranate peel extract against Giardia
lamblia infection.1. Introduction
Giardia lamblia (G. lamblia) (syn. Giardia intestinalis,
Giardia duodenalis) is a ﬂagellated protozoan that infects
the human small intestine, causing a disease called giardiasis.
It is one of the common zoonotic infectious parasites wide-
spread all over the world [1]. Globally, it is estimated that
approximately 280 million people per year are infected with
Giardia [2]. It is also an opportunistic parasite and it is the
main cause of acute and chronic diarrhea and malnutrition in
poor communities, with a prevalence range between 10%
and 50% in developing countries [2–5]. Epidemics indeveloped countries might be attributed to inappropriate
water treatment, water contamination with human or animal
faeces, particularly from surface water collections and lakes
[6]. It is reported that the incidence of this parasite among
children in temperate countries has reached 25%, and
the proportion rises remarkably in the tropics with up to
50%–80% of the population carriers of the parasite. In Saudi
Arabia, incidence rates of 28% make the parasite G. lamblia
the most prevalent parasite among children [7]. Furthermore,
Giardia is the most common human intestinal parasite
in many developed countries. Giardiasis is transmitted by
the ingestion of cysts present in food and water; water
dissemination being easier due to cysts resistance to
chlorination [8,9]. Direct transmission from person to person
is another infection mechanism, through direct faecal-oral
contact among members of the same family [10], particularly
in collective institutions, such as children in daycare centers
and orphanages [11], and by sexual practices (oral-anal
contact) [12]. Despite its signiﬁcance and scope giardiasis is
still considered a neglected disease by the World Health
Organization. Since it occurs primarily in the poorestarticle under the CC BY-NC-ND license (http://
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health, pregnancy and worker productivity, imparing the
ability of those infected individuals to achieve their full
potential, thus affecting their socio-economic development
[4,13]. The symptomatology of human giardiasis is extremely
variable; many individuals have the asymptomatic form
while others have nausea, abdominal pain, chronic or
acute diarrhea, which may last several months, thus
causing malabsorption and weight loss [14–16]. Several
studies have reported genetic variations among Giardia
samples isolated from human beings. These differences are
thought to signiﬁcantly inﬂuence giardiasis epidemiology and
control, especially for host susceptibility, drug sensitivity,
antigenicity, and in vivo and in vitro development [17].
Eventhough some advances have been observed in isolating
and characterizing Giardia samples, few studies have been un-
dertaken regarding this parasite's chemotherapy [18]. Some
studies have reported resistance to different drugs which
have been used for the treatment of this disease and the
number of cases is likely to increase [19–21]. Numerous
chemotherapeutic drugs such as furazolidone, quinacrine,
paromomycin, benzimidazole compounds, 5-nitroimidazole
compounds, nitazoxanide, have been used as a therapy for
giardiasis. In Saudi Arabia, metronidazole and nitroimidazole
are the common treatment for giardiasis. A short period of
treatment is most effective with a cure rate of approximately
90% after a week [22]. However, most drugs used have
considerable adversarial side effects and they are
contraindicated [23,24]. Furthermore, Giardia appears to have a
great capability to ﬁght against these drugs [21,24]. Moreover,
the Food and Drug Administration US refuses to ratify
metronidazole due to the serious side effects as being
carcinogenic factors in mice and rats and mutagenic in
bacteria [25]. Further problems caused are severe inﬂammation
of the pancreas and brain [26], and it may also lead to embryo
abnormalities [22]. Consequently, there is a need for more
studies into medicinal plants or herbs for alternative regimens
against giardiasis. A recent study by Mahmoud et al. [27]
conﬁrmed the efﬁciency of ginger and cinnamon extracts as a
promising alternative therapy to the commonly used
antigiardial drugs. Pomegranate, viz. Punica granatum
(Punicaceae) (P. granatum), described as nature's power fruit,
a plant used in folkloric medicine for the treatment of various
diseases [28], is widespread in the Mediterranean region.
Pomegranate contains very high levels of antioxidant
compounds with anti-inﬂammatory properties [28,29]. In
addition, it has antifungal action against Trichophyton rubrum
[30]. In spite of the many studies which have been conducted
to examine the efﬁcacy of pomegranate for treating diseases
and microbial infections, to-date still much remains unknown
about its effects on parasitic infections. Various studies indicate
that pomegranate extract shows positive effects in the suppres-
sion of intestinal cestodes and trematodes [31–34] and anti-
protozoan activities [35,36]. Recently, some studies have
reported that pomegranate peel is a promising treatment for
Cryptosporidium parvum and it is effective as an anti-
coccidial as well as a anthelmintic that does not induce side
effects [37,38]. Furthermore, ELISA was recently used as a
diagnostic method for detection of different soluble antigen
rather than cysts detection [39].
The main aim of this study was to determine the efﬁcacy of
pomegranate (P. granatum) from Saudi Arabia as an alternativeand safe treatment of giardiasis through experimental study on
the white laboratory mice. Stool cyst counts ELISA was also
used for antigen detection.2. Materials and methods
2.1. Animals
Fifty male Swiss albino mice (Mus musculus), free from any
intestinal parasitic infection, aged 3–4 weeks and weighing 25–
35 g each, were obtained from the animal facilities of King
Saud University, Riyadh, Saudi Arabia. The mice were bred
under speciﬁed pathogen-free conditions and fed with feed (P
684) of the General Organization for Grain Silos and Flour
Mills production in Riyadh, Kingdom of Saudi Arabia. To
ensure that mice are free from intestinal parasites, stool sam-
ples were examined for three consecutive days before starting
the experiment. Smears were directly swabbed after addition of
D'Antoni's iodine [40]. The experiments were approved by state
authorities and followed Saudi Arabian rules for animal
protection.
2.2. Source of the parasite
G. lamblia cysts were obtained from fresh stool samples of
outpatients at King Khalid University in Riyadh, Saudi Arabia,
where microscopic examination showed that there were cysts per
each microscopic ﬁeld (400×). Informed written consent was
obtained from outpatients.
2.3. Infection of mice
Each mouse was orally inoculated with Giardia cyst 105/mL
cyst. Subsequently, fresh faecal pellets were collected every 24 h
to be sure they become infected [41]. The collected pellets from
each group were weighed, and the bedding was changed to
eliminate re-infection.
2.4. Preparation of the pomegranate peel extract
P. granatum peels were obtained from fruit purchased from
a local market. According to the method described by Abdel
Moneim [28], pomegranate peel extract was prepared with
slight modiﬁcations. Air-dried powder (100 g) of pome-
granate peels was extracted by percolation with 70% methanol
at room temperature and then kept at 4 C for 24 h. Thereafter,
the extract was concentrated under reduced pressure (bath
temperature 50 C) and dried in a vacuum evaporator. The
residue was dissolved in distilled water and used in this
experiment [38].
2.5. Experimental design
Animals were divided into ﬁve groups, ten animals in each
group. Three groups were assigned as the control groups. Group
1 was infected with 105/mL of Giardia infestation cysts. Group
2 was fed daily for 7 days before infection and throughout the
experimental period by oral gavage with citrus pectin (Sigma)
which consists of a complex set of polysaccharides. Group 3 was
fed daily starting from 7th day of infection and throughout the
experimental period by oral gavage with citrus pectin until the
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experimental groups. Group 4 was fed daily for 7 days before
infection and throughout the experimental period by oral gavage
with 100 mL pomegranate peel extract (300 mg/kg). Group 5
was fed daily starting from 7th day of infection. The dose and
the route of injection were selected on the basis of the previous
studies [37].Table 1
Rate of detection Giardia cysts in the stool among the different studies
groups.
Groups Numbers of cysts in stool
Day 10 Day 15 Day 20
* * *2.6. Parasitological studies
2.6.1. Determination of the infection
The stool samples were microscopically examined on daily
basis starting from the ﬁrst day of the infection up to the time-
point when the Giardia cysts were detected and the mice were
infected.Control
groups
1 11.80 ± 2.15 10.60 ± 1.17 8.60 ± 0.69
2 11.10 ± 1.66b* 9.60 ± 0.84ab* 8.40 ± 0.96a*
3 11.60 ± 1.95b* 9.70 ± 0.94ab* 8.50 ± 0.70a*
Experimental
groups
4 5.70 ± 0.67b** 2.80 ± 0.63a* 1.10 ± 0.73a*
Reduction
%
51.69% 73.85% 87.20%
5 7.10 ± 0.73b** 3.80 ± 0.78a* 2.10 ± 0.99a*
Reduction
%
39.80% 64.10% 75.60%
Data are expressed as mean ± SD. Different letters indicate signiﬁcant2.6.2. Determination of the infection intensity
After conﬁrmation of the infection, the intensity of infection
on Days 10, 15 and 20 was determined as described by Roberts-
Thomson et al. [42]. Detection of Giardia parasite antigen in the
animals stool in the Days 5, 7, 14, 21 and 28 after infection was
performed by ELISA using the monoclonal antibodies (ProSpect
Giardia Microplate Assay, Remel).differences in the Tukey test. P-value represents the relationships among
groups in one row. *: P  0.05; **: P  0.001.2.7. Statistical analysis
The data were statistically processed using One-way
ANOVA, and the statistical comparisons among the groups
were performed with Duncan's multiple range test using a
Microsoft Excel 2010. A probability level of P < 0.05 was
chosen to indicate signiﬁcant differences among the means.
Means connected with stars are considered signiﬁcantly different
from each other.
3. Results
In the present investigation, the effect of pomegranate peel
extract on G. lamblia infections was investigated as an anti-
Giardia material. It was observed that 10 days following
infection by G. lamblia, the production of cysts differed be-
tween pomegranate-treated and un-treated mice. In the former,
the rates of excreted cysts reached 5.70 ± 0.67 and 7.10 ± 0.73
in those treated 7 days prior to infection and those starting
treatment 7 days post-infection, respectively. Cysts excretion
was reduced by about 50% on Day 10 in the experimentalTable 2
Rate of detection Giardia antigen in the stool among the different studies gr
Groups
Day 5 Day
Control groups 1 0.74 ± 0.09** 8.15 ±
2 0.66 ± 0.08** 8.19 ±
3 0.71 ± 0.07** 8.19 ±
Experimental groups 4 0.48 ± 0.12** 4.08 ±
Reduction % 35.1% 49.9
5 0.77 ± 0.09** 7.71 ±
Reduction % 0.0% 5.3
Data are expressed as mean ± SD. P-value represents the relationships amogroup compared with the control group. Furthermore, by Day
20 post-infection, the pomegranate treatment signiﬁcantly
lowered the shedding of cysts to approximately 75.6%, as
shown in Table 1. However, the rates of cysts production were
signiﬁcantly different on Days 10, 15 and 20 in control groups.
On the other hand, the differences among the experimental
groups were signiﬁcant regarding the number of cyst detected
on Days 10, 15 and 20.As shown in Table 2, immunological investigations indi-
cated that the detection rates of Giardia antigen in the stool by
ELISA test displayed gradual reduction in Giardia antigen in
the stool of the experimental groups which received pome-
granate extract compared with control groups. However, the
Giardia antigen reduction rate in the experimental groups
which were fed with pomegranate extract from 7th days of
infection reached 35.1% and 96.8% on Days 5 and 28,
respectively. Furthermore, Giardia antigen in the experimental
groups which were fed with pomegranate extract 7th days after
infection didn't show reduction on Day 5, but on Day 28 the
highest Giardia antigen reduction rate was observed. In
contrast, control groups didn't show any improvement.
Generally, the dose used in the experimental groups induced
noticeable reduction in the number of cysts. Furthermore, using
pomegranate peel extract before infection showed higher
ability to reduce the infection rate and the number of cyst
produced compared with using the extract after infection. This
observation was also recorded for Giardia antigen detection in
the stool till Day 14.oups.
Giardia antigen in stool
7 Day 14 Day 21 Day 28
0.68** 20.05 ± 0.92** 18.40 ± 1.03** 17.90 ± 0.83**
1.12** 20.15 ± 1.32** 18.34 ± 1.54** 16.79 ± 0.77**
0.76** 19.91 ± 0.93** 18.46 ± 0.84** 17.92 ± 0.81**
1.06** 3.19 ± 0.99** 1.07 ± 0.39** 0.56 ± 0.24**
% 84.1% 94.0% 96.8%
1.13** 3.67 ± 1.20** 0.51 ± 0.11* 0.45 ± 0.09**
% 81.6% 97.2% 97.4%
ng groups in one row. *: P  0.05; **: P  0.001.
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Giardia infects both adults and children in developed coun-
tries worldwide and is currently responsible for the largest
number of water-borne outbreaks of diarrhea [43,44].
Metronidazole drug for the treatment of intestinal infections
caused by G. lamblia is reported to have unpleasant side
effects [25,35]. Development of parasite resistance to treatment
besides the negative side effects of conventional drugs might
be the main reasons that lead experts to look for safe and
effective alternative agents for the Giardia treatment. Globally,
herbal curatives have been studied under controls and was
technologically approved by researchers in many countries
[45]. An additional constraint in using anti-Giardia medications
comes from the consumer and the ever-increasing demand for
the drug-free production of foods [46] as they are not only natural
products, but may also include new therapeutic molecules to
which resistance has not yet developed [38]. Pomegranate peel
extract which contains biologically active components may be
active against diarrhea [47]. In the present investigation,
pomegranate peel extract was examined as an alternative and
effective medication for treatment and protection against
G. lamblia. The extraction procedure is an important factor
that affects the efﬁcacy of the plant extract as a treatment
against infections. The type of solvent used for the extraction
process is also of critical importance and considered a key
factor that affects the positive determination of biologically
active compounds from plant origin. The most commonly used
solvents for investigation of antimicrobial activity from plant
materials are organic solvents (methanol and ethanol) and
water [48]. In this investigation, the methanol extract of
pomegranate peel was tested for anti-Giardia activity and it
demonstrated positive results. Experimental groups treated
with extract of pomegranate peel in this study showed cysts
reduction on the 10th day after infection. Moreover, curing
rate was highly signiﬁcant in the experimental group which
reached 73.85% on Day 15 post-infection, indicating the effec-
tiveness of pomegranate peel extract as an anti-Giardia therapy.
These results were in agreement with El-Shennawy et al. [49]
who noted 72.15% reduction of Giardia in a group receiving
pomegranate peel extract. Furthermore, antigen detection was
signiﬁcantly reduced in the P. granatum-treated mice by the
14th day post infection and was mostly eliminated by the 28th
day post infection. These results were supported by Al-Mathal
and Alsalem [37]. Many other studies have reported
pomegranate peel as an effective anti-protozoan treatment
[35,36]. Furthermore, signiﬁcant improvement in the antioxidant
status and protection of the host tissue from injuries induced
by pomegranate extract has been well documented by Dkhil
[38]. This might be the main reason for the reduction rate of
cysts in treated mice with pomegranate peel extract. In
addition, El-Shennawy et al. [49] recorded a remarkable
decrease manifested by high percentage of dead adult worms
of Schistosoma (72.2%) treated with pomegranate peel extract.
Moreover, several studies indicated that peel extracts of
P. granatum could represent promising bioactive natural
agents such as anti-parasites that deserve further investigations
[37,45,50]. Mansour et al. [51] found higher concentration of
phenolic compounds such as gallic acid, ellagic acid, caffeic
acid, p-coumaric acid, quercetin, and vanillic acid in
methanolic pomegranate peels extract than water extract.
Concentration of these compounds could be the main reasonfor the potential giardicidal activity of methanolic pomegranate
peel extract investigated in this study.
In conclusion, the results of the present study reinforced the
effectiveness of peel extracts of (P. granatum) as a safe treat-
ment against giardiasis through experimental study on the white
laboratory mice. Peel extracts have proven to be valuable agents
in prevention and treatment of G. lamblia infection, and will
form basis for further investigation of pomegranate efﬁcacy
against other parasites. Moreover, it indicates potential discov-
ery of new natural biologically active compounds and the
accumulation of traditional knowledge about plants used for the
treatment of giardiasis. Further investigations are needed to
identify the active ingredients in pomegranate peel and to
perform toxicity test to identify safe levels for use.Conﬂict of interest statement
We declare that we have no conﬂict of interest.
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